Increased blood viscosity and red blood cell aggregation in patients with COVID‐19
E Nader, C Nougier, C Boisson… - American journal of …, 2022 - Wiley Online Library
The aim of this study was to (1) analyze blood viscosity, red blood cell (RBC) deformability,
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …
Impact of COVID‐19 on red blood cell rheology.
C Renoux, R Fort, E Nader, C Boisson… - British journal of …, 2021 - search.ebscohost.com
Abstract Keywords: COVID-19; red blood cell; deformability; aggregation; blood viscosity EN
COVID-19 red blood cell deformability aggregation blood viscosity e108 e111 4 02/17/21 …
COVID-19 red blood cell deformability aggregation blood viscosity e108 e111 4 02/17/21 …
[HTML][HTML] Blood viscosity of COVID-19 patient: a preliminary report
B Joob, V Wiwanitkit - American journal of blood research, 2021 - ncbi.nlm.nih.gov
COVID-19 is the important global problem. This new coronavirus can cause several
hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19 …
hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19 …
Even patients with mild COVID‐19 symptoms after SARS‐CoV‐2 infection show prolonged altered red blood cell morphology and rheological parameters
M Grau, L Ibershoff, J Zacher, J Bros… - Journal of cellular …, 2022 - Wiley Online Library
Infection with the novel severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)
and the associated coronavirus disease‐19 (COVID‐19) might affect red blood cells (RBC); …
and the associated coronavirus disease‐19 (COVID‐19) might affect red blood cells (RBC); …
[HTML][HTML] Altered platelet and coagulation function in moderate-to-severe COVID-19
To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs …
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs …
[PDF][PDF] Physical phenotype of blood cells is altered in COVID-19
M Kubánková, B Hohberger, J Hoffmanns, J Fürst… - Biophysical journal, 2021 - cell.com
Clinical syndrome coronavirus disease 2019 (COVID-19) induced by severe acute
respiratory syndrome coronavirus 2 is characterized by rapid spreading and high mortality …
respiratory syndrome coronavirus 2 is characterized by rapid spreading and high mortality …
[HTML][HTML] Characteristics of coagulation alteration in patients with COVID-19
H Luo, C You, S Lu, Y Fu - Annals of hematology, 2021 - Springer
Abnormal blood coagulation often occurs in critically ill patients, which seriously affects their
prognosis. This retrospective study investigated the implications of changes in blood …
prognosis. This retrospective study investigated the implications of changes in blood …
[HTML][HTML] Rotational thromboelastometry results are associated with care level in COVID-19
LM Almskog, A Wikman, J Svensson… - Journal of Thrombosis …, 2021 - Springer
High prevalence of thrombotic events in severely ill COVID-19 patients have been reported.
Pulmonary embolism as well as microembolization of vital organs may in these individuals …
Pulmonary embolism as well as microembolization of vital organs may in these individuals …
[HTML][HTML] SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood …
C Bao, X Tao, W Cui, B Yi, T Pan, KH Young… - … Hematology & Oncology, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is a novel infectious viral
disease, which lacks well-established diagnostic laboratory parameters that could be used …
disease, which lacks well-established diagnostic laboratory parameters that could be used …
Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity
AD Truong, SC Auld, NA Barker, S Friend… - …, 2021 - Wiley Online Library
Background Recent data suggests an association between blood hyperviscosity and both
propensity for thrombosis and disease severity in patients with COVID‐19. This raises the …
propensity for thrombosis and disease severity in patients with COVID‐19. This raises the …